{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T17:20:35Z","timestamp":1698600035045},"reference-count":36,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":5137,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1995,4]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> We assayed granulocyte\u2010macrophage committed progenitor cells (CFU\u2010GM) in the peripheral blood of 34 patients with chronic lymphocytic leukemia (CLL) and 12 normal individuals. The patients were divided into separate groups on the basis of previous therapy (i.e. analysis performed at diagnosis, during and after chemotherapy) and clinical features of the disease (i.e. disease stage, pattern of bone marrow infiltration, peripheral blood lymphocytosis). The mean CFU\u2010GM colony count of the patients was 30 times higher than that of the controls (206.4 \u00b1 197.8 (SD) CFU\u2010GM per 5 times 10<jats:sup>5<\/jats:sup> cells plated versus 6.5 \u00b1 3.6). There was no statistical difference in the numbers of circulating CFU\u2010GM between the patients studied at diagnosis (257 \u00b1 215.4 CFU\u2010GM\/5 times 10<jats:sup>5<\/jats:sup> cells) and those studied during (117.6 \u00b1 169.2 CFU\u2010GM\/5 times 10<jats:sup>5<\/jats:sup> cells) or after chemotherapy (207.5 \u00b1 105.9 CFU\u2010GM\/5 times 10<jats:sup>5<\/jats:sup> cells), although a trend towards a higher recovery of myeloid progenitors was observed as a function of time elapsing from the last treatment. In addition, we found no significant difference in the <jats:italic>in vitro<\/jats:italic> CFU\u2010GM growth of patients grouped according to their disease stage, pattern of bone marrow infiltration and degree of peripheral blood lymphocytosis. In conclusion, our data indicate that intensification with peripheral blood stem cell support may be feasible in CLL, since progenitor cells of myeloid\u2010monocytic series are markedly increased in the peripheral blood of these patients. Moreover, it is possible to extend this kind of therapy to patients who have undergone previous extensive chemotherapy and who might have persisting bone marrow infiltration.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1995.tb00677.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T04:47:22Z","timestamp":1279428442000},"page":"235-240","source":"Crossref","is-referenced-by-count":4,"title":["Increased peripheral blood normal myeloid progenitor cells (CFU\u2010GM) in chronic lymphocytic leukemia: A perspective for autologous peripheral blood stem cell transplantation"],"prefix":"10.1111","volume":"54","author":[{"given":"Costas","family":"Tsatalas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panayota","family":"Chalkia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Athanasiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Venizelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos","family":"Karakolios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Kakoulidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Bouricas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-5-671"},{"key":"e_1_2_1_3_2","first-page":"457","article-title":"Fludarabine monophosphate: A potentially useful agent in chronic lymphocytic leukemia","volume":"30","author":"Grever MR","year":"1988","journal-title":"Nouv Rev Fr Hematol"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.1.19.bloodjournal74119"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.1.44"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood.V80.1.29.29","article-title":"Response assessment in chronic lymphocytic leukemia after fludarabine plus prednizone: Clinical, pathologic, immunophenotypic, and molecular analysis","volume":"80","author":"Robertson LE","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.3.1069.bloodjournal7231069"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199109103394"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.4.433"},{"issue":"1","key":"e_1_2_1_10_2","first-page":"66a","article-title":"Purged autologous bone marrow transplantation for chronic lymphocytic leukemia: preliminary results","volume":"80","author":"Khouri I.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.4.1366.1366"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530110302"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1985.tb02888.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1040830218"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1982.tb03910.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V46.2.219.219"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1182\/blood.V67.5.1298.1298","article-title":"High\u2010dose melphalan with autologous bone marrow transplantation for multiple myeloma","volume":"67","author":"Barlogie B.","year":"1986","journal-title":"Blood"},{"issue":"51","key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-0609.1989.tb01509.x","article-title":"High\u2010dose chemotherapy and autologous bone marrow transplantation for myeloma","volume":"43","author":"McElwain TJ","year":"1989","journal-title":"Eur J Haematol"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V73.7.1749.bloodjournal7371749"},{"key":"e_1_2_1_21_2","first-page":"87","volume-title":"Bone marrow transplantation in practice","author":"Chopra R.","year":"1992"},{"key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood.V70.3.869.869","article-title":"High dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma","volume":"70","author":"Barlogie B.","year":"1987","journal-title":"Blood"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.11.2524.2524"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(88)80029-9"},{"key":"e_1_2_1_25_2","first-page":"266","article-title":"Ablative therapy supported by autologous bone marrow transplantation (ABMT) as consolidation of remission in patients with follicular lymphoma","volume":"8","author":"Rohatiner AZS","year":"1989","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_26_2","first-page":"693","volume-title":"Are occult tumor cells present in peripheral stem cell harvests of candidates for autologous transplantation","author":"Sharp JG","year":"1989"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood.V73.1.20.20","article-title":"Treatment of aggressive multiple myeloma by high\u2010dose chemotherapy and total body irradiation followed by blood stem cells autologous graft","volume":"73","author":"Fermand JP","year":"1989","journal-title":"Blood"},{"issue":"1","key":"e_1_2_1_28_2","first-page":"55","article-title":"Autologous blood stem cell transplantation in high\u2010risk multiple myeloma","volume":"5","author":"Marit G.","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_29_2","first-page":"1013","article-title":"High\u2010dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging","volume":"19","author":"Kessinger A.","year":"1991","journal-title":"Exp Haematol"},{"key":"e_1_2_1_30_2","first-page":"467","article-title":"Intensive radio\u2010chemotherapy with peripheral blood stem cell transplantation in young patients with chronic lymphocytic leukemia","volume":"10","author":"Bastion Y.","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_31_2","first-page":"351","article-title":"CFU\u2010mix are no better than CFU\u2010GM in predicting haemopoietic reconstitutive capacity of peripheral blood stem cells collected in the very early remission phase of acute lymphoblastic leukaemia","volume":"15","author":"To LB","year":"1987","journal-title":"Exp Haematol"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197409)34:3<663::AID-CNCR2820340324>3.0.CO;2-2"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(86)90272-9"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.3109\/10408368409165768"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/256041a0"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V47.6.1031.1031"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)92012-0"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1995.tb00677.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1995.tb00677.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T03:38:47Z","timestamp":1698377927000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1995.tb00677.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,4]]}},"alternative-id":["10.1111\/j.1600-0609.1995.tb00677.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1995.tb00677.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,4]]}}}